| PACKAGING TYPE: | 10x10 Alu-alu (10 Strips In 1 Box) |
| COMPOSITION: | Febuxostat 40mg |
| FORMULATION: | Tablet |
| Description: | FELATOR 40 Tablet contains Febuxostat 40mg, a xanthine oxidase inhibitor used for the management of hyperuricemia (elevated uric acid levels) in patients with gout. Febuxostat works by inhibiting the xanthine oxidase enzyme, reducing the production of uric acid in the body. This helps in preventing gout attacks, reducing joint inflammation, and minimizing the risk of long-term complications such as kidney stones and joint damage. FELATOR 40 is commonly used as an initial or maintenance dose in gout management. |
| Side Effects: | Common side effects: Nausea Headache Joint pain Mild skin rash Rare but serious side effects: Liver function abnormalities Cardiovascular events in high-risk patients Severe allergic reactions (rash, swelling, difficulty breathing) Initial increase in gout flare-ups |
| How to Use: | Take FELATOR 40 Tablet orally, usually once daily or as prescribed. Can be taken with or without food. Swallow the tablet whole with water. Continue therapy regularly for best results. Do not discontinue without consulting your doctor. |
| Precaution: | Monitor uric acid levels and liver function periodically. Use cautiously in patients with cardiovascular disease or liver impairment. Initial treatment may trigger temporary gout attacks. Inform your doctor about all medications to avoid interactions. Not recommended during pregnancy or breastfeeding without medical advice. |
| Product Benefits: | Helps lower uric acid levels effectively. Prevents gout flare-ups and joint inflammation. Reduces pain, swelling, and stiffness associated with gout. Suitable for long-term management of hyperuricemia. Helps prevent uric acid crystal deposition and ki |
Frequently Asked Questions
FELATOR 40 is used to reduce uric acid levels and prevent gout attacks in patients with hyperuricemia.
Yes, it is typically used for long-term management of uric acid levels under medical supervision.
Yes, some patients may experience temporary gout attacks at the start of treatment as uric acid levels begin to change.










